Ani Pharmaceuticals, Inc. (BSFA)
XSTU
64.00
+0.50 (+0.79%)
Real-time Data
06:00 AM
Day's Range
63.0064.50
52 wk Range
59.5084.00
Financial Statements - BSFA - Ani Pharmaceuticals, Inc.
Revenue
883.36M▲ 43.8%
Net Income
78.33M▲ 522.9%Net Margin 8.9%
EBITDA
174.58M▲ 164.9%
Free Cash Flow
150.90M▲ 220.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 883.36M | 614.37M | 486.81M | 316.38M | 216.13M | 208.47M |
| Cost of Goods | 341.31M | 250.21M | 181.51M | 138.78M | 100.61M | 87.15M |
| Gross Profit | 542.05M | 364.16M | 305.30M | 177.60M | 115.52M | 121.31M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 81.23M | 2.21M | 49.52M | -25.73M | -28.16M | -15.57M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 34.62M | -6.82M | -2.71M | -8.87M | -15.96M | -940K |
| Pre Tax Income | 95.79M | -22.21M | 19.87M | -62.66M | -56.05M | -25.96M |
| Income Tax | 17.45M | -3.69M | 1.09M | -14.76M | -13.45M | -3.41M |
| Net Income | 78.33M | -18.52M | 18.77M | -47.89M | -42.60M | -22.54M |
| EPS Basic | 3.5 | -1.04 | 0.86 | -3.05 | -3.4 | -1.88 |
| EPS Diluted | 3.32 | -1.04 | 0.85 | -3.05 | -3.4 | -1.88 |
| Basic Shares Outstanding | 20.05M | 19.31M | 18.68M | 16.69M | 12.93M | 12.28M |
| Diluted Shares Outstanding | 20.05M | 19.31M | 18.68M | 16.69M | 12.93M | 12.28M |
| Ebit | 115.85M | -4.61M | 46.81M | -34.61M | -44.13M | -16.51M |
| Ebitda | 174.58M | 65.91M | 109.16M | 34.58M | 14.74M | 28.57M |
| Net Income Continuous Operations | 78.33M | -18.52M | 18.77M | -47.89M | -42.60M | -22.54M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 6.96M | - | - | - | - | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
